Business
Accuray ClearRT™ Helical Fan-Beam kVCT Imaging Wins "Best New Technology Solution for Oncology" MedTech Breakthrough Award
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies SUNNYVALE, Calif., May 5, 2022 /PRNewswire/ -- Accuray
About this update from Accuray Incorporated
[{"type":"text","content":"Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies\nSUNNYVALE, Calif., May 5, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that its ClearRT™ helical fan-beam kVCT imaging capability for the Radixact® System has been selected as the winner of the \"Best New Technology Solution for Oncology\" award in the sixth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough. An independent market intelligence organization, MedTech Breakthrough recognizes the top companies, technologies and products in the global health and medical technology market.\n\n \n \n \n \n \n \n\n \nThe Accuray TomoTherapy® System ushered in a new era in cancer care with 3D image-guided radiotherapy to improve treatment delivery. The Radixact System, the latest evolution of the TomoTherapy platform, in combination with ClearRT, makes it practical for radiation oncology departments of all sizes to easily, quickly and cost effectively acquire diagnostic-like quality CT images when treating tumors with radiation. The ClearRT technology is designed to provide higher quality imaging that improves the precision and accuracy of radiation treatment delivery.\nClearRT offers enhanced imaging capabilities compared to conventional linear accelerators that rely on cone-beam CT (CBCT) imaging, and provides an alternative to MR-based radiotherapy systems that are contraindicated for some patients, such as those with metal implants, and cost prohibitive to use. ClearRT also integrates with other Accuray applications, such as Synchrony®, which adapts treatment delivery to tumor motion in real time as the patient breathes naturally, without uncomfortable patient restraints, breath-hold techniques, or interrupting treatment.\n\"The entire Accuray team is honored by this recognition from MedTech Breakthrough that reflects our heritage of developing innovative, 'breakthrough' technologies that truly advance patient care. ClearRT is the most recent example of an Accuray-proprietary solution that is making it possible for our customers to do more, better and faster, when delivering radiation therapy treatments,\" said Joshua H. Levine, chief executive officer of Accuray. \"Ultimately, it's about patients. We believe they should have more time with the people they love and doing the activities...